The Myriad myRisk report provides recommendations for managing patients with either positive or negative genetic results. SALT LAKE CITY, Aug. 13, 2020 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad” or the “Company”), a global leader in molecular diagnostics and precision medicine, today announced financial results for its fiscal fourth-quarter 2020 and … A genetic expert will determine your cancer risks and talk with you about the option of genetic testing, if applicable. For testing, a small amount of blood will be drawn or a saliva sample is taken and sent to Myriad for analysis. Patients input personal and family history into myGeneHistory. Patient care begins with knowledge, and every patient deserves to know the most about their cancer. Myriad Oncology offers a suite of tests for eight different cancer types that provide critical information regarding your or your patients’ disease. Test results will be available in about two to three weeks. Myriad Complete is a proprietary suite of services to help your patients through the genetic testing process, each designed to assist you as you determine the best care plan for your patient’s individual needs. The Myriad Prequel Prenatal Screen is a noninvasive prenatal screen that uses cell-free DNA (cfDNA) to determine if a pregnancy is at an increased risk for common chromosome abnormalities, such as Down syndrome. Myriad Genetics’ diagnostic tests provide results that include a genetic testing status and medical recommendations. Review of Myriad Genetics diagnostic testing reports The first section of the report provides a summary of the mutations identified from the genetic test. ... We deliver screening and testing results effectively and thoroughly so you can focus on care plans. I am a provider looking for accurate and actionable test results that provide a clear picture into my patients’ cancer and their hereditary cancer risk. Therefore, it is important for patients and their families to ask questions about the potential meaning of genetic test results both before and after the test … Myriad myRisk ® Hereditary Cancer Test. Help patients get ahead of cancer with our hereditary cancer test. I am a patient or caregiver looking for answers that will help guide cancer treatment decisions and provide peace of mind for my family and me. Did you share your genetic test results with members of your family? Once completed, the patient and you will be informed if they meet guidelines for genetic testing. Yes No. YOUR PARTNER IN PATIENT CARE . MANAGE Test results will be available in about two to three weeks. Talking about the pros and cons and focusing on the facts can be helpful as you consider your options. Every Myriad myRisk test report includes: The Myriad myRisk Genetic Test Result and The Myriad myRisk Management Tool – a personalized cancer risk and management guide based on professional medical society guidelines. Myriad Oncology genetic testing provides insights into cancer, treatment options, and if your family is at risk for developing hereditary cancers. It is important to obtain informed consent from the patient before submitting a sample to Myriad for testing. Did you encourage members of your family to get tested for hereditary cancer? Myriad Genetics is a molecular diagnostics company, which provides testing services designed to assess an individual’s risk of developing a disease. MYRIAD GENETICS | 320 Wakara Way | Salt Lake City, UT 84108 | (800) 469-7423. Consults. If you choose to have genetic testing, a genetic expert can explain your results to you. cfDNA screening has been shown to be superior to methods that use maternal age, ultrasound, and serum screening. MYRIAD GENETICS | 320 Wakara Way | Salt Lake City, UT 84108. Results from myGeneHistory are automatically saved into your MyriadPro account where you’ll be able to order Myriad genetics tests quickly and easily. Total Third-Quarter Revenues of $164.0 MillionThird-Quarter Diluted EPS of ($1.55) and Adjusted EPS of ($0.08) SALT LAKE CITY, May 05, 2020 -- Myriad Genetics, Inc. (NASDAQ:. For testing, a small amount of blood will be drawn, or a saliva sample or biopsy is taken, and sent to Myriad for analysis. The report then describes the significance of any mutations found. Total Second-Quarter Revenues of $195.1 MillionSecond-Quarter Diluted EPS of ($0.11) and Adjusted EPS of $0.23 SALT LAKE CITY, Feb. 06, 2020 -- Myriad Genetics, Inc. (NASDAQ:. The results of genetic tests are not always straightforward, which often makes them challenging to interpret and explain. SALT LAKE CITY, Nov. 04, 2019 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN, “Myriad” or the “Company”), a global leader in molecular diagnostics and precision medicine, today announced financial results for its fiscal first-quarter 2020, provided an update on recent business highlights and provided revised fiscal year and second-quarter 2020 financial guidance. At Myriad, we are committed to providing the highest-quality laboratory testing and delivering accurate, clinically actionable results to help you make better, more informed decisions.